Drug Use-Results Survey of Betanis Tablets 25 and 50 mg

Trial Profile

Drug Use-Results Survey of Betanis Tablets 25 and 50 mg

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society
    • 02 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 21 May 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top